| Patent | Date |
|---|
Knottin-immunostimulant Conjugates And Related Compositions And Methods
App 20220257785 - Sagiv-Barfi; Idit ; et al. | 2022-08-18 |
Immolative Cell-penetrating Complexes For Nucleic Acid Delivery To The Lung
App 20220143199 - BLAKE; Tim R. ; et al. | 2022-05-12 |
Hybrid Immolative Cell-penetrating Complexes For Nucleic Acid Delivery
App 20220088163 - BLAKE; Tim R. ; et al. | 2022-03-24 |
Treatment Using Bruton's Tyrosine Kinase Inhibitors And Immunotherapy
App 20200397895 - Levy; Ronald ; et al. | 2020-12-24 |
Humanized and chimeric monoclonal antibodies to CD81
Grant 10,815,306 - Levy , et al. October 27, 2 | 2020-10-27 |
Methods for enhancing anti-tumor antibody therapy
Grant 10,633,450 - Kohrt , et al. | 2020-04-28 |
Methods And Compositions For Determining Responsiveness To Antibody Therapy
App 20200017915 - Levy; Ronald ; et al. | 2020-01-16 |
Humanized And Chimeric Monoclonal Antibodies To Cd81
App 20190177425 - Levy; Shoshana ; et al. | 2019-06-13 |
Humanized and chimeric monoclonal antibodies to CD99
Grant 10,040,862 - Liu , et al. August 7, 2 | 2018-08-07 |
Methods For Enhancing Anti-tumor Antibody Therapy
App 20180208670 - Kohrt; Holbrook ; et al. | 2018-07-26 |
Immolative Cell-penetrating Complexes For Nucleic Acid Delivery
App 20180028688 - Waymouth; Robert M. ; et al. | 2018-02-01 |
Methods for enhancing anti-tumor antibody therapy
Grant 9,758,589 - Kohrt , et al. September 12, 2 | 2017-09-12 |
Method of predicting responsiveness of B cell lineage malignancies to active immunotherapy
Grant 9,605,320 - Alizadeh , et al. March 28, 2 | 2017-03-28 |
Humanized And Chimeric Monoclonal Antibodies To Cd99
App 20170029524 - Liu; Jie ; et al. | 2017-02-02 |
Medical Uses Of Cd38 Agonists
App 20160235842 - Goldstein; Matthew J. ; et al. | 2016-08-18 |
Methods for Enhancing Anti-Tumor Antibody Therapy
App 20160083474 - Kohrt; Holbrook ; et al. | 2016-03-24 |
Methods And Compositions For Determining Responsiveness To Antibody Therapy
App 20150315660 - Levy; Ronald ; et al. | 2015-11-05 |
Methods and compositions for determining responsiveness to antibody therapy
Grant 9,109,255 - Levy , et al. August 18, 2 | 2015-08-18 |
Treatment Using Bruton's Tyrosine Kinase Inhibitors And Immunotherapy
App 20150118222 - LEVY; Ronald ; et al. | 2015-04-30 |
Methods for enhancing anti-tumor antibody therapy
Grant 9,005,619 - Kohrt , et al. April 14, 2 | 2015-04-14 |
Method of Predicting Responsiveness of B Cell Lineage Malignancies to Active Immunotherapy
App 20140220562 - Alizadeh; Arash Ash ; et al. | 2014-08-07 |
Immunogenic protein constructs
Grant 8,481,045 - Swartz , et al. July 9, 2 | 2013-07-09 |
Methods for Enhancing Anti-Tumor Antibody Therapy
App 20120321646 - Kohrt; Holbrook ; et al. | 2012-12-20 |
Methods of Prognosis for Non-Hodgkin Lymphoma
App 20120134986 - Alizadeh; Arash Ash ; et al. | 2012-05-31 |
Immunogenic Protein Constructs
App 20110129438 - Swartz; James Robert ; et al. | 2011-06-02 |
Immunogenic Protein Constructs
App 20100183655 - Swartz; James Robert ; et al. | 2010-07-22 |
Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression
App 20100143926 - Levy; Ronald ; et al. | 2010-06-10 |
Classification of patients having diffuse large b-cell lymphoma based upon gene expression
Grant 7,622,253 - Levy , et al. November 24, 2 | 2009-11-24 |
Classification of patients having diffuse large B-cell lymphoma based upon gene expression
Grant 7,332,280 - Levy , et al. February 19, 2 | 2008-02-19 |
Classification of patients having diffuse large B-cell lymphoma based upon gene expresson
App 20070026453 - Levy; Ronald ; et al. | 2007-02-01 |
Design of therapeutics and therapeutics
App 20060018911 - Ault-Riche; Dana ; et al. | 2006-01-26 |
Methods and compositions for determining responsiveness to antibody therapy
App 20060008825 - Levy; Ronald ; et al. | 2006-01-12 |
Classification of patients having diffuse large B-cell lymphoma based upon gene expression
App 20050079513 - Levy, Ronald ; et al. | 2005-04-14 |
Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo
App 20040101522 - Panicali, Dennis L. ; et al. | 2004-05-27 |
Methods and compositions for determining neoplastic disease responsiveness to antibody therapy
App 20030219818 - Bohen, Sean P. ; et al. | 2003-11-27 |
Receptor-binding antiproliferative peptides
Grant 5,512,435 - Renschler , et al. April 30, 1 | 1996-04-30 |
Monoclonal anti-idiotype antibodies
Grant 4,661,586 - Levy , et al. April 28, 1 | 1987-04-28 |
Assay for monoclonal antibody against surface Ig of a human B cell tumor
Grant 4,513,088 - Levy , et al. April 23, 1 | 1985-04-23 |
| 